Section Arrow
EYEN.NASDAQ
- Eyenovia
(Financial Status)
Quotes are at least 15-min delayed:2024/12/24 12:48 EST
Last
 0.0849
+0.0004 (+0.47%)
Day High 
0.0865 
Prev. Close
0.0845 
1-M High
0.1293 
Volume 
2.54M 
Bid
0.0844
Ask
0.0845
Day Low
0.0823 
Open
0.0858 
1-M Low
0.077 
Market Cap 
9.42M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.09 
20-SMA 0.09 
50-SMA 0.29 
52-W High 2.57 
52-W Low 0.077 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.69/-0.46
Enterprise Value
19.67M
Balance Sheet
Book Value Per Share
0.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.79K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.383-0.0201-4.99%-- 
CMNDClearmind Medicine1.67+0.45+36.89%0.16PE
CEROCERo Therapeutics Holdings0.0603+0.0098+19.41%-- 
RXRXRecursion Pharmaceuticals7.3081+0.3181+4.55%-- 
CDTConduit Pharmaceuticals0.057699+0.003199+5.87%-- 
Quotes are at least 15-min delayed:2024/12/24 12:48 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.